Multidisciplinary treatment of the patient with a severe irritable bowel syndrome
- Authors: Ruchkina I.N.1, Vyaznikova A.A.1, Indeykina L.K.1, Degterev D.A.1, Parfenov A.I.1
-
Affiliations:
- Loginov Moscow Clinical Scientific Practical Center
- Issue: Vol 92, No 2 (2020)
- Pages: 81-84
- Section: Consensuns
- URL: https://journals.rcsi.science/0040-3660/article/view/33913
- DOI: https://doi.org/10.26442/00403660.2020.02.000523
- ID: 33913
Cite item
Full Text
Abstract
The patient E., aged 39, was described with a severe form of the irritable bowel syndrome that developed after the stress. In addition to the clinical manifestations of IBS, the patient got the somatoform disorders, which manifested itself with a large number of extraintestinal symptoms and led to a disability. According to the recommendations of the Rome Criteria IV 2016, the main medicines for the treatment of biopsychosocial model of IBS are antidepressants. The remission of the disease with a complete recovery of the patient’s disability was achieved by duloxetine, an antidepressant from the group of serotonin and noradrenaline reuptake inhibitors.
Full Text
##article.viewOnOriginalSite##About the authors
I. N. Ruchkina
Loginov Moscow Clinical Scientific Practical Center
Email: 207lec@mail.ru
д.м.н., в.н.с. отд. невоспалительной патологии кишечника
Russian Federation, MoscowA. A. Vyaznikova
Loginov Moscow Clinical Scientific Practical Center
Author for correspondence.
Email: 207lec@mail.ru
м.н.с. лаб. функциональной диагностики заболеваний кишечника
Russian Federation, MoscowL. K. Indeykina
Loginov Moscow Clinical Scientific Practical Center
Email: 207lec@mail.ru
зав. лаб. функциональной диагностики заболеваний кишечника
Russian Federation, MoscowD. A. Degterev
Loginov Moscow Clinical Scientific Practical Center
Email: 207lec@mail.ru
к.м.н., зав. неврологическим отд-нием
Russian Federation, MoscowA. I. Parfenov
Loginov Moscow Clinical Scientific Practical Center
Email: 207lec@mail.ru
д.м.н., проф., зав. отд. патологии кишечника
Russian Federation, MoscowReferences
- Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035
- Маев И.В., Черемушкин С.В., Кучерявый Ю.А. Синдром раздраженного кишечника. Римские критерии IV. О роли висцеральной гиперчувствительности и способах ее коррекции. Методическое пособие. М., 2016. 64 с. [Maev IV, Cherjomushkin SV, Kucherjavyj JuA. Irritable bowel syndrome. Rome-IV criteria. The role of visceral hypersensitivity and methods for its correction. Toolkit. Moscow, 2016. 64 p. (In Russ.)].
- Lacy BE, Mearin F, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;150:1393-407. doi: 10.1053/j.gastro.2016.02.031
- Ивашкин В.Т., Шелыгин Ю.А., Баранская Е.К. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению синдрома раздраженного кишечника. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(5):76-93 [Ivashkin VT, Shelygin YuA, Baranskaya EK, et al. Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(5):76-93 (In Russ.)]. doi: 10.22416/1382-4376-2017-27-5-76-93
- Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, et al. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol. 2016;14:1602-11. doi: 10.1016/j.cgh.2016.05.033
- Данилов Ан.Б., Данилов Ал.Б. Управление болью. Руководство для врачей различных специальностей. M.: АММ Пресс, 2016 [Danilov AnB, Danilov AlB. Сontrol of pain. A guide for doctors of various specialties. Moscow: AMM Press, 2016 (In Russ.)].
- Парфенов А.И., Албулова Е.А., Ручкина И.Н. Синдром раздраженного кишечника в свете Римского консенсуса III (2006 г.): 10 лет спустя. Терапевтический архив. 2016;88(2):4-9 [Parfenov AI, Albulova EA, Ruchkina IN. Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later. Therapeutic Archive. 2016;88(2):4-9 (In Russ.)]. doi: 10.17116/terarkh20168824-9
- Oblizajek NR, Gandhi S, Sharma M, Chakraborty S, Muthyala A, Prichard D, et al. Anorectal pressures measured with high‐resolution manometry in healthy people – Normal values and asymptomatic pelvic floor dysfunction. J Neurogastroenterol Motil. 2019 Jul;31(7):e13597. doi: 10.1111/nmo.13597
- Kaplan A, Franzen MD, Nickell PV, Ransom D, Lebovitz PJ. An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder. Int J Psychiatry Clin Pract. 2014;18(1):11-5. doi: 10.3109/13651501.2013.838632. Epub 2013 Sep 20.
- Дюкова Г.М., Погромов А.П., Леонова М.Л. Эффективность антидепрессанта двойного действия в терапии функциональных расстройств желудочно-кишечного тракта. Медицинский совет. 2014;(3):78-80 [Dyukova GM, Pogromov AP, Leonova ML, et al. Effect of the dual action antidepressant duloxetine in the treatment of functional disorders of the gastrointestinal tract. Medical Council. 2014;(3):78-80 (In Russ.)]. doi: 10.21518/2079-701X-2014-4-78-81
- Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, Naliboff BD. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004 Jul 1;20(1):89-97. doi: 10.1111/j.1365-2036.2004.02007.x